InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Waksal Harlan, Chairman & CEO. Insider active across 3 companies, notably Kadmon Holdings, Inc.. Cumulatively, 5 disclosures have been recorded. Total volume traded: €924k. The latest transaction was filed on 12 April 2022 — Acquisition. Regulator: SEC (Form 4). The full history is free.
Declarations5 total
€923,687236,966 shares@ €3.89874.35% mcap100.0% of flow
Common Stock
SEC:0000899243-22-014737:0·
Ideal exit: 7 Jan 2023 (T+270)
€1m177,945 shares@ €8.1956100.0% of flow
Common Stock
SEC:0001104659-21-136412·
€1m177,945 shares@ €8.195648.8% of flow
Common Stock
SEC:0001104659-21-136412:0·
€73,67325,000 shares@ €2.9469100.0% of flow
Common Stock
SEC:0001593968-21-001330·
€73,67325,000 shares@ €2.94692.5% of flow
Common Stock
SEC:0001593968-21-001330:0·
5 of 5 declarations
About Waksal Harlan
Harlan Waksal serves as President & CEO and Executive Chair at Kadmon Holdings, Inc. and Lyra Therapeutics, Inc. In this role, he oversees the operations and strategy of both companies. His experience in the biopharmaceutical sector allows him to make significant contributions to growth and innovation.
